Elevance Health (ELV) rises 2.6% as Q3 results tighten margin focus and 2026 guidance is raised
FROM THE WIRE · FINANCE.YAHOO.COM
Elevance Health just posted its Q3 2026 scorecard and the stock has shrugged off any hesitation. Shares are up 2.6% today to about US$445 even as earnings per share of US$6.30 sit below the prior quarter and net income is US$1.37b on more than US$51b of revenue. That is the…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA large health insurer's shares react to raised guidance, even though quarterly profit fell below the prior quarter.AI-generated summary
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets